Page 113 - GPD-2-1
P. 113

Gene & Protein in Disease                                          Autoimmune thyroid disease in narcolepsy



            sufficient  data  to  demonstrate  whether  AITD  is  more   4.   Andlauer O, Moore HT 4 , Hong SC, et al., 2012, Predictors
                                                                                     th
            likely to occur in narcolepsy patients. Therefore, the   of hypocretin (orexin) deficiency in narcolepsy without
            future studies should focus on autoimmune disorders   cataplexy. Sleep, 35(9): 1247–1255F.
            in larger sample sizes of narcolepsy patients to explore      https://doi.org/10.5665/sleep.2080
            the pathophysiological mechanisms of narcolepsy with   5.   Liblau RS, Vassalli A, Seifinejad A, et al., 2015, Hypocretin
            immunopathological diseases. This would allow us to   (orexin) biology and the pathophysiology of narcolepsy with
            better understand the significance of immune-related   cataplexy. Lancet Neurol, 14(3): 318–328.
            processes in the pathophysiology of these disorders.
                                                                  https://doi.org/10.1016/s1474-4422(14)70218-2
            Acknowledgments                                    6.  Kachooei-Mohaghegh-Yaghoobi  L,  Rezaei-Rad  F,

            None.                                                 Sadeghniiat-Haghighi K,  et al., 2020, The impact of the
                                                                  HLA DQB1 gene and amino acids on the development of
            Funding                                               narcolepsy. Int J Neurosci, 132(7): 706–713.
                                                                  https://doi.org/10.1080/00207454.2020.1835903
            No funding was received in drafting this manuscript.
                                                               7.   Bourgin P, Zeitzer JM, Mignot E, 2008, CSF hypocretin-1
            Conflict of interest                                  assessment in sleep and neurological disorders.  Lancet
                                                                  Neurol, 7(7): 649–662.
            The authors have no conflict of interest to declare.
                                                                  https://doi.org/10.1016/s1474-4422(08)70140-6
            Author contributions                               8.   Martinez-Orozco FJ, Vicario JL, Villalibre-Valderrey I,

            Data curation: Chaofan Geng                           et al.,  2014,  Narcolepsy  with  cataplexy  and  comorbid
            Writing – original draft: Chaofan Geng, Zhenzhen Yang  immunopathological diseases. J Sleep Res, 23(4): 414–419.
            Writing – review & editing: Hongju Zhang              https://doi.org/10.1111/jsr.12143
            Ethics approval and consent to participate         9.   Johns MW, 1991, A new method for measuring daytime
                                                                  sleepiness: The epworth sleepiness scale. Sleep, 14(6): 540–545.
            The research protocol of this study was approved by the      https://doi.org/10.1093/sleep/14.6.540
            Research Ethics Committee of Henan Provincial People’s
            Hospital.  The  patient/participant  provided  a  written   10.  Peraita-Adrados R, Lammers GJ, De Andres C, et al., 2013, A
            informed consent to participate in this study.        patient with narcolepsy with cataplexy and multiple sclerosis:
                                                                  Two  different  diseases  that may  share  pathophysiologic
            Consent for publication                               mechanisms? Sleep Med, 14(7): 695–696.
                                                                  https://doi.org/10.1016/j.sleep.2013.03.015
            A written informed consent was obtained from the patient
            for the publication of any potentially identifiable images or   11.  Ekbom K, 1966, Familial multiple sclerosis associated with
            data included in this article.                        narcolepsy. Arch Neurol, 15(4): 337–344.
                                                                  https://doi.org/10.1001/archneur.1966.00470160003001
            Availability of data
                                                               12.  Schuld A, Hebebrand J, Geller F,  et al., 2000, Increased
            The data presented in the study can be obtained from the   body-mass index in patients with narcolepsy.  Lancet,
            corresponding author on reasonable request.           355(9211): 1274–1275.
            References                                            https://doi.org/10.1016/s0140-6736(05)74704-8
                                                               13.  Cohen A, Mandrekar J, St Louis EK,  et al., 2018,
            1.   Bassetti CL, Adamantidis A, Burdakov D,  et al., 2019,   Comorbidities in a community sample of narcolepsy. Sleep
               Narcolepsy-clinical  spectrum,  aetiopathophysiology,  Med, 43: 14–18.
               diagnosis and treatment. Nat Rev Neurol, 15(9): 519–539.
                                                                  https://doi.org/10.1016/j.sleep.2017.11.1125
               https://doi.org/10.1038/s41582-019-0226-9
                                                               14.  Poli F, Pizza F, Mignot E, et al., 2013, High prevalence of
            2.   Postiglione E, Antelmi E, Pizza F, et al., 2018, The clinical   precocious puberty and obesity in childhood narcolepsy
               spectrum of childhood narcolepsy. Sleep Med Rev, 38: 70–85.
                                                                  with cataplexy. Sleep, 36(2): 175–181.
               https://doi.org/10.1016/j.smrv.2017.04.003
                                                                  https://doi.org/10.5665/sleep.2366
            3.   Luo G, Yogeshwar S, Lin L, et al., 2021, T cell reactivity to   15.  Chabas D, Foulon C, Gonzalez J,  et al., 2007, Eating
               regulatory factor X4 in Type 1 narcolepsy. Sci Rep, 11(1): 7841.
                                                                  disorder and metabolism in narcoleptic patients.  Sleep,
               https://doi.org/10.1038/s41598-021-87481-8         30(10): 1267–1273.


            Volume 2 Issue 1 (2023)                         4                      https://doi.org/10.36922/gpd.v2i1.235
   108   109   110   111   112   113   114   115   116   117   118